BEAM
Beam Therapeutics Inc
NASDAQ: BEAM · HEALTHCARE · BIOTECHNOLOGY
$29.38
-3.86% today
Updated 2026-04-29
Market cap
$3.02B
P/E ratio
—
P/S ratio
21.60x
EPS (TTM)
$-0.81
Dividend yield
—
52W range
$15 – $36
Volume
2.1M
Beam Therapeutics Inc (BEAM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.71M | $-20.30M | $-72.00M | $-95.74M | $-66.27M | $22.53M | $-149.19M | $-347.25M | $-345.10M |
| Capital expenditures | $346000.00 | $13.12M | $12.52M | $16.36M | $46.81M | $48.95M | $33.73M | $8.95M | $14.95M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $198000.00 | $7.00M | $7.03M | $15.38M | $43.57M | $84.32M | $98.65M | $120.66M | $94.24M |
| Free cash flow | $-3.05M | $-33.42M | $-84.52M | $-112.10M | $-113.08M | $-26.42M | $-182.93M | $-356.19M | $-360.05M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $12.71M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $395.73M | — | — | — | — |